Salarius Pharmaceuticals, Inc. (SLRX) Stock Analysis
DELISTED 2026
What happened to Salarius Pharmaceuticals, Inc. (SLRX) stock?
Salarius Pharmaceuticals, Inc. (SLRX) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- January 2026
- Last recorded price (historical):
- $0.84 (last quote on record before the January 2026 delisting; historical, not a current quote)
Market cap $4.92M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Salarius Pharmaceuticals, Inc. (SLRX). Salarius Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing epigenetic-based cancer treatments. Their lead candidate, Seclidemstat (SP-2577), is currently in Phase I/II clinical trials.
Last analyzed: Mar 18, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Salarius Pharmaceuticals, Inc. (SLRX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy SLRX shares?
No. SLRX stopped trading on public markets in January 2026, so the shares are not available through a broker. Anything you see quoted for SLRX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SLRX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Salarius Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.